426 related articles for article (PubMed ID: 18509648)
21. Genetic Phagocyte NADPH Oxidase Deficiency Enhances Nonviable Candida albicans-Induced Inflammation in Mouse Lungs.
Endo D; Fujimoto K; Hirose R; Yamanaka H; Homme M; Ishibashi KI; Miura N; Ohno N; Aratani Y
Inflammation; 2017 Feb; 40(1):123-135. PubMed ID: 27785664
[TBL] [Abstract][Full Text] [Related]
22. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
Romani L; Fallarino F; De Luca A; Montagnoli C; D'Angelo C; Zelante T; Vacca C; Bistoni F; Fioretti MC; Grohmann U; Segal BH; Puccetti P
Nature; 2008 Jan; 451(7175):211-5. PubMed ID: 18185592
[TBL] [Abstract][Full Text] [Related]
23. Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.
Wenger RH; Marti HH; Schuerer-Maly CC; Kvietikova I; Bauer C; Gassmann M; Maly FE
Blood; 1996 Jan; 87(2):756-61. PubMed ID: 8555500
[TBL] [Abstract][Full Text] [Related]
24. Phagocyte NADPH oxidase and specific immunity.
Cachat J; Deffert C; Hugues S; Krause KH
Clin Sci (Lond); 2015 May; 128(10):635-48. PubMed ID: 25760962
[TBL] [Abstract][Full Text] [Related]
25. Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells.
Deffert C; Carnesecchi S; Yuan H; Rougemont AL; Kelkka T; Holmdahl R; Krause KH; Schäppi MG
J Pathol; 2012 Nov; 228(3):341-50. PubMed ID: 22685019
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
27. Bioluminescence imaging of NADPH oxidase activity in different animal models.
Han W; Li H; Segal BH; Blackwell TS
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23117583
[TBL] [Abstract][Full Text] [Related]
28. Treatment with Polyethylene Glycol-Conjugated Fungal D-Amino Acid Oxidase Reduces Lung Inflammation in a Mouse Model of Chronic Granulomatous Disease.
Nunoi H; Xie P; Nakamura H; Aratani Y; Fang J; Nishimura T; Kataoka H; Maeda H; Matsukura M
Inflammation; 2022 Aug; 45(4):1668-1679. PubMed ID: 35211862
[TBL] [Abstract][Full Text] [Related]
29. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
[TBL] [Abstract][Full Text] [Related]
30. Low interleukin-17A production in response to fungal pathogens in patients with chronic granulomatous disease.
Smeekens SP; Henriet SS; Gresnigt MS; Joosten LA; Hermans PW; Netea MG; Warris A; van de Veerdonk FL
J Interferon Cytokine Res; 2012 Apr; 32(4):159-68. PubMed ID: 22191467
[TBL] [Abstract][Full Text] [Related]
31. Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.
Rajakariar R; Newson J; Jackson EK; Sawmynaden P; Smith A; Rahman F; Yaqoob MM; Gilroy DW
J Immunol; 2009 Mar; 182(5):3262-9. PubMed ID: 19234224
[TBL] [Abstract][Full Text] [Related]
32. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
[TBL] [Abstract][Full Text] [Related]
33. Tryptophan/kynurenine metabolism in human leukocytes is independent of superoxide and is fully maintained in chronic granulomatous disease.
De Ravin SS; Zarember KA; Long-Priel D; Chan KC; Fox SD; Gallin JI; Kuhns DB; Malech HL
Blood; 2010 Sep; 116(10):1755-60. PubMed ID: 20511543
[TBL] [Abstract][Full Text] [Related]
34. Recent topics and advanced therapies in chronic granulomatous disease.
Nunoi H; Nakamura H; Nishimura T; Matsukura M
Hum Cell; 2023 Mar; 36(2):515-527. PubMed ID: 36534309
[TBL] [Abstract][Full Text] [Related]
35. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
de Luca A; Smeekens SP; Casagrande A; Iannitti R; Conway KL; Gresnigt MS; Begun J; Plantinga TS; Joosten LA; van der Meer JW; Chamilos G; Netea MG; Xavier RJ; Dinarello CA; Romani L; van de Veerdonk FL
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3526-31. PubMed ID: 24550444
[TBL] [Abstract][Full Text] [Related]
36. Chronic Granulomatous Disease: a Comprehensive Review.
Yu HH; Yang YH; Chiang BL
Clin Rev Allergy Immunol; 2021 Oct; 61(2):101-113. PubMed ID: 32524254
[TBL] [Abstract][Full Text] [Related]
37. Regulation of innate immunity by NADPH oxidase.
Segal BH; Grimm MJ; Khan AN; Han W; Blackwell TS
Free Radic Biol Med; 2012 Jul; 53(1):72-80. PubMed ID: 22583699
[TBL] [Abstract][Full Text] [Related]
38. Granuloma Formation in a
Prieto-Bermejo R; Romo-González M; Pérez-Fernández A; García-Macías MC; Sánchez-Bernal C; García-Tuñón I; Sánchez-Yagüe J; Sánchez-Martín M; Hernández-Hernández Á
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445407
[TBL] [Abstract][Full Text] [Related]
39. Chronic granulomatous disease: why an inflammatory disease?
Roxo-Junior P; Simão HM
Braz J Med Biol Res; 2014 Nov; 47(11):924-8. PubMed ID: 25296353
[TBL] [Abstract][Full Text] [Related]
40. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease.
Dinauer MC; Gifford MA; Pech N; Li LL; Emshwiller P
Blood; 2001 Jun; 97(12):3738-45. PubMed ID: 11389011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
